Topics

We engage in flexible partnership models, including research collaborations, venture capital investments, academic alliances for drug development, early stage seed funding, establishing incubators, licensing, and spinning out of companies. https://on.pfi

14:59 EST 15 Jan 2020 | Pfizer

We engage in flexible partnership models, including research collaborations, venture capital investments, academic alliances for drug development, early stage seed funding, establishing incubators, licensing, and spinning out of companies. https://on.pfizer.com/2TriBbs 

Original Article: We engage in flexible partnership models, including research collaborations, venture capital investments, academic alliances for drug development, early stage seed funding, establishing incubators, licensing, and spinning out of companies. https://on.pfi

NEXT ARTICLE

More From BioPortfolio on "We engage in flexible partnership models, including research collaborations, venture capital investments, academic alliances for drug development, early stage seed funding, establishing incubators, licensing, and spinning out of companies. https://on.pfi"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...